Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology
- Status
- COMPLETED
- Phase
- NA
Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
MEtatastic Renal Carcinoma LINes
- Status
- UNKNOWN
- Phase
- N/A
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
- Status
- UNKNOWN
- Phase
- N/A
SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Tazemetostat Expanded Access Program for Adults With Solid Tumors
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of TRK-950 in Combinations With Anti-Cancer Treatment Regimens in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
- Status
- UNKNOWN
- Phase
- PHASE2
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
- Status
- RECRUITING
- Phase
- PHASE2
Post-marketing Surveillance on the Safety of CabometyxTM in Korean Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of EDP1503 in Patients With Colorectal Cancer, Breast Cancer, and Checkpoint Inhibitor Relapsed Tumors
- Status
- COMPLETED
- Phase
- PHASE1